Researchers at Georgia State University have developed a new universal flu vaccine that offers broad defense against different strains of the influenza B virus. The double-layered protein nanoparticle vaccine, which is constructed with a stabilized portion of the influenza virus, induced broadly reactive immune responses and conferred robust and sustained cross-immune protection against the virus. The nanoparticle vaccine was tested in cell culture and in mice.
An official website of the United States government.